Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

IBS

Origins Insights Offering Explained

Origins believe that the patient voice not only should but must be included at all stages of the product lifecycle, we believe the question is no longer about why, but...

Origins – The Patient Focused Specialists

- PMLiVE

MS Awareness Week – Matt’s story

Matt is 31 and was diagnosed with multiple sclerosis, a chronic immune mediated inflammatory condition, two years ago. Around 100,000 people in the UK are affected by MS and it...

Mednet Group

- PMLiVE

Virtual Science AI introduces new advisory platform

The platform offers the life sciences industry a new tool for online interactions with HCPs, patient communities and decision-makers

Advancing Drug Discovery with Structured and Intelligent Data

Michael Wilson and Craig Knox, co-founders of DrugBank, discuss how their comprehensive drug database can be used together with AI and machine learning for drug discovery and repurposing, clinical research,...

Impetus Digital

S Marchant (L) A Korving (C) D Youds (R)

RESONANT GROUP APPOINTS STEPHEN MARCHANT CHIEF DEVELOPMENT OFFICER

Stephen Marchant has joined Resonant Group in the newly created role of Chief Development Officer.  He will be working with the Board to create, grow and acquire businesses and services to...

Origins – The Patient Focused Specialists

- PMLiVE

The Unknown Unknowns

Patient insights are fundamental to ensuring we understand the reality of living with a condition. We need to consciously  challenge our approach and ensure we are unearthing authentic patient insights that...

Bedrock Healthcare Communications

Patient-Owned Online Marketplace for Patient Insights

Jen Horonjeff, Founder & CEO of Savvy Cooperative, talks about how her personal health journey and experience as a chronic disease patient lead to her founding Savvy Cooperative. We also discuss...

Impetus Digital

- PMLiVE

Irritable Bowel Syndrome (IBS) patient insights

It’s common. It’s debilitating. We’re talking about IBS. In this issue of MAGNIFI, we explore the insights of patients suffering with IBS, while also looking into research around the HCP–patient...

IGNIFI

SWITCHED ONcology Patient Experience Focus Group Full Discussion

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. In...

Havas Lynx

SWITCHED ONcology Patient Experience Focus Group Highlights

On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. "We...

Havas Lynx

- PMLiVE

NICE backs Allergan’s IBS therapy Truberzi

The £3 per day therapy was recommended in final guidance from the cost-effectiveness watchdog

Shifting perceptions of the use of probiotics in IBS Management

Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range...

Research Partnership

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links